Voclosporin

伏环孢素

Report date: 2026/03/09 20:02:04
NME

Base Information

Drug NameVoclosporin
Drug Alias NameVoclosporinum沃环孢素VoclosporineVoclosporinaLuveniq +[18] 
ClassificationSmall molecules > Molecular Glue
Mechanisms of ActionCalcineurin inhibitors
TargetsCalcineurin
Therapy Area/IndicationsRejection of renal transplantationCoronavirus Disease 2019 (COVID-19)Psoriasis +[10] 
Global Approved IndicationsLupus Nephritis
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2021/01/22
Country/TerritoryCanadaUnited StatesPoland +[10] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesAurinia
China Registration ClassN/A

Develop Information

Active Companies3sbio IncLeiden University Medical CenterAurinia Pharmaceuticals Inc +[6] 
Inactive CompaniesNational Institute Of Allergy And Infectious Diseases (Niaid)Qilu Pharmaceutical Co LtdOtsuka Pharmaceuticals
Active IndicationsRejection of renal transplantationCoronavirus Disease 2019 (COVID-19)Lupus Nephritis
Inactive IndicationsPsoriasisLupus Erythematosus, SystemicGlomerulosclerosis, Focal Segmental +[7] 

Other Information

ATC CodeL04AD03
Related LinksWikipediaKEGG